DE68926813D1 - Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide - Google Patents

Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide

Info

Publication number
DE68926813D1
DE68926813D1 DE68926813T DE68926813T DE68926813D1 DE 68926813 D1 DE68926813 D1 DE 68926813D1 DE 68926813 T DE68926813 T DE 68926813T DE 68926813 T DE68926813 T DE 68926813T DE 68926813 D1 DE68926813 D1 DE 68926813D1
Authority
DE
Germany
Prior art keywords
antibodies
cellular receptors
antique
antigens
specificity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68926813T
Other languages
English (en)
Other versions
DE68926813T2 (de
Inventor
Mark Greene
William Williams
David Weiner
Jeffrey Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of DE68926813D1 publication Critical patent/DE68926813D1/de
Application granted granted Critical
Publication of DE68926813T2 publication Critical patent/DE68926813T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE68926813T 1988-05-13 1989-04-28 Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide Expired - Fee Related DE68926813T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19402688A 1988-05-13 1988-05-13
US32632889A 1989-03-21 1989-03-21
PCT/US1989/001815 WO1989010939A1 (en) 1988-05-13 1989-04-28 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens

Publications (2)

Publication Number Publication Date
DE68926813D1 true DE68926813D1 (de) 1996-08-14
DE68926813T2 DE68926813T2 (de) 1997-07-17

Family

ID=26889616

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926813T Expired - Fee Related DE68926813T2 (de) 1988-05-13 1989-04-28 Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide

Country Status (5)

Country Link
EP (1) EP0370090B1 (de)
JP (1) JPH02504284A (de)
AT (1) ATE140233T1 (de)
DE (1) DE68926813T2 (de)
WO (1) WO1989010939A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
ATE229974T1 (de) * 1990-09-14 2003-01-15 Univ Pennsylvania Design von bioaktiven peptiden auf der basis von immunglobulin strukturen
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683295A (en) * 1984-05-24 1987-07-28 Scripps Clinic And Research Foundation Method for the preparation of anti-receptor antibodies
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
EP0241139A3 (de) * 1986-03-13 1989-04-19 Merck & Co. Inc. Antiidiotypischer Coccidiaimpfstoff
AU620804B2 (en) * 1987-03-23 1992-02-27 Hiver Limited Novel vaccines
DE3853779T2 (de) * 1987-05-29 1995-09-07 Tanox Biosystems Inc Hiv-1 neutralisierende monoklonale antikörper.

Also Published As

Publication number Publication date
EP0370090A4 (en) 1990-12-05
JPH02504284A (ja) 1990-12-06
EP0370090A1 (de) 1990-05-30
WO1989010939A1 (en) 1989-11-16
EP0370090B1 (de) 1996-07-10
ATE140233T1 (de) 1996-07-15
DE68926813T2 (de) 1997-07-17

Similar Documents

Publication Publication Date Title
NL300303I1 (nl) CTL4A receptor, fusie-eiwitten die deze receptor bevatten, en toepassing ervan.
EP0330506A3 (de) VLA-Proteine
DE68918867T2 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
ATE109795T1 (de) Htlv-iii umhüllende peptiden.
KR880006357A (ko) 인터류킨-i에 대한 항체
ATE87368T1 (de) Monoklonale antikoerper gegen nicht reduzierte, nicht enzymatisch glykolysierte proteine.
DK0920509T3 (da) Polypeptider, der er i stand til at danne antigenbindende strukturer med specificitet for Rhesus D-antigener, DNA, der koder herfor, samt fremgangsmåde til fremstilling heraf og anvendelse heraf
WO1999013907A3 (en) Methods to improve immunogenicity of antigens and specificity of antibodies
DE68926813T2 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
KR890003958A (ko) 단일클로온 항체들에 의해 확인되는 리스테리아속-특이 항원
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
DE69026875T2 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ES2061664T3 (es) Anticuerpos monoclonales que reconocen a alfa-hanp y correspondientes hibridomas, su preparacion y uso.
ES2055066T3 (es) Anticuerpos monoclonales que reconocen el extremo n del gamma polipeptido natriuretico atrial, hibridomas que los producen y su preparacion y aplicacion.
KR910005887A (ko) 면역원성 물질의 고-보존된 아미노산 서열에 대한 항체, 이의 항체의 제조 방법 및 면역 감정에서의 이의 용도
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
DK340887A (da) Antigenisk peptid isoleret fra 28 kd proteinet fras. mansoni og fremgangsmaade til dets isolering, monoklonale antistoffer, der genkender mindst en epitop af peptidet og dets anvendelse til syntese af antistoffer
JPS6471480A (en) Cell line producing monoclonal antibody and monoclonal antibody produced therefrom
JPS6471481A (en) Cell line producing monoclonal antibody and monoclonal antibody produced therefrom

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: COMPETITIVE TECHNOLOGIES, INC., WESTPORT, CONN., U

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, PH

8339 Ceased/non-payment of the annual fee